Earnings History Data for Myriad Genetics, Inc. (MYGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Myriad Genetics, Inc.

Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2024 AH MYGN Myriad Genetics, Inc. 1,870 -0.07 -0.05 -0.20 Myriad Genetics Non-GAAP EPS of $0.04 beats by $0.03, revenue of $196.6M beats by $1.97M
[2/27/2024 4:38 PM]		 21.64 -1.86 
(-7.91%)		 23.25 -0.25 
(-1.06%)		 13.82 - 24.21 961,874 550,000 804
06-11-2023 AH MYGN Myriad Genetics, Inc. 1,310 -0.17 -0.16 -0.27 Myriad Genetics Non-GAAP EPS of -$0.03 beats by $0.05, revenue of $191.9M beats by $12.8M
[11/6/2023 4:17 PM]		 17.77 1.43 
(8.75%)		 16.00 -0.34 
(-2.08%)		 13.82 - 24.21 738,924 630,000 12,841
03-08-2023 AH MYGN Myriad Genetics, Inc. 1,780 -0.21 -0.18 -0.06 Myriad Genetics Non-GAAP EPS of -$0.08 beats by $0.01, revenue of $183.5M misses by $3.36M
[8/3/2023 4:28 PM]		 19.29 -1.47 
(-7.08%)		 20.00 -0.76 
(-3.66%)		 13.92 - 28.18 1,035,113 410,000 1,053
03-05-2023 AH After the close
(May 3)		 MYGN Myriad Genetics, Inc. 1,770 -0.28 -0.28 -0.14 Myriad Genetics reports Q1 results, narrows FY 2023 guidance
[5/3/2023 4:38 PM]		 21.00 -0.89 
(-4.07%)		 21.89 0.0 
(0.00%)		 13.92 - 28.18 590,131 440,000 142,260
28-02-2023 AH After the close
(Feb 28)		 MYGN Myriad Genetics, Inc. 1,500 -0.20 -0.27 -0.11 Myriad Genetics Non-GAAP EPS of -$0.12 beats by $0.05, revenue of $177.8M beats by $8.38M
[2/28/2023 4:38 PM]		 21.49 2.57 
(13.58%)		 18.92 0.0 
(0.00%)		 13.92 - 28.18 796,964 660,000 52,879
01-11-2022 PM 7:05 AM ET
(Nov 1)		 MYGN Myriad Genetics, Inc. 1,680 -0.27 -0.15 -0.12 Myriad Genetics Non-GAAP EPS of -$0.19 misses by $0.11, revenue of $156.4M misses by $13.97M, updates FY guidance
[11/1/2022 9:12 AM]		 17.51 -3.23 
(-15.57%)		 18.00 -2.74 
(-13.21%)		 15.94 - 32.00 972,091 470,000 1,947
04-08-2022 PM 4:05 PM ET
(Aug 4)		 MYGN Myriad Genetics, Inc. 1,960 -0.06 -0.09 0.03 Myriad Genetics GAAP EPS of $0.04 beats by $0.19, revenue of $179.3M beats by $9.25M
[8/4/2022 7:48 AM]		 27.40 1.47 
(5.67%)		 3.92 -0.40 
(-9.26%)		 16.02 - 36.95 633,692 560,000 51,552
05-05-2022 PM 4:05 PM ET
(May 5)		 MYGN Myriad Genetics, Inc. 1,700 -0.14 -0.15 -0.16 Myriad Genetics Non-GAAP EPS of -$0.03 beats by $0.06, revenue of $164.9M beats by $8.81M
[5/5/2022 9:06 AM]		 21.60 -0.25 
(-1.14%)		 21.85 0.0 
(0.00%)		 20.26 - 36.95 697,830 510,791 23,295
24-02-2022 PM 4:05 PM ET
(Feb 24)		 MYGN Myriad Genetics, Inc. 2,050 -0.11 -0.15 -0.19 Myriad Genetics Non-GAAP EPS of -$0.02 beats by $0.04, revenue of $160.8M misses by $1.41M
[2/24/2022 9:11 AM]		 24.96 1.16 
(4.87%)		 0.0 0.0 
(0.00%)		 0.0 - 0.0 323,537 0 0
02-11-2021 PM 4:05 PM ET
(Nov 2)		 MYGN Myriad Genetics, Inc. 2,500 -0.12 -0.12 -0.19 Myriad Genetics EPS misses by $0.01, beats on revenue
[11/2/2021 8:37 AM]		 30.80 -0.39 
(-1.25%)		 30.80 0.0 
(0.00%)		 12.55 - 36.95 464,438 430,000 7,516
03-08-2021 PM 7:00 AM ET
(Aug 3)		 MYGN Myriad Genetics, Inc. 2,440 0.03 -0.20 -0.33 Myriad Genetics EPS beats by $0.22, beats on revenue
[8/3/2021 7:31 AM]		 35.26 4.40 
(14.26%)		 30.86 0.0 
(0.00%)		 11.76 - 35.34 2,011,235 420,000 10,635
03-05-2021 AH 4:05 PM ET
(May 3)		 MYGN Myriad Genetics, Inc. 2,330 -0.16 -0.22 -0.16 Myriad Genetics EPS beats by $0.09, beats on revenue
[5/3/2021 4:49 PM]		 31.61 1.21 
(3.98%)		 30.40 0.0 
(0.00%)		 10.54 - 33.97 667,437 490,000 199,893
23-02-2021 AH 4:05 PM ET
(Feb 23)		 MYGN Myriad Genetics, Inc. 2,360 -0.19 -0.23 0.15 Myriad Genetics EPS in-line, beats on revenue
[2/23/2021 4:37 PM]		 30.07 1.04 
(3.58%)		 29.03 0.0 
(0.00%)		 9.24 - 31.59 643,516 701,828 18,326
09-11-2020 PM 4:05 PM ET
(Nov 9)		 MYGN Myriad Genetics, Inc. 1,060 -0.19 -0.42 -0.03 Myriad Genetics EPS beats by $0.15, beats on revenue
[11/9/2020 8:14 AM]		 17.02 0.83 
(19.10%)		 14.95 0.66 
(4.62%)		 9.24 - 30.13 1,137,872 470,371 6,667
13-08-2020 AH 4:05 PM ET
(Aug 13)		 MYGN Myriad Genetics, Inc. 926.71 -0.33 -0.49 0.30 Myriad Genetics EPS beats by $0.18, beats on revenue
[8/13/2020 4:11 PM]		 12.35 -1.03 
(-7.70%)		 13.40 0.02 
(0.15%)		 9.24 - 35.29 1,548,779 650,814 12,773
05-05-2020 AH 4:05 PM ET
(May 5)		 MYGN Myriad Genetics, Inc. 1,100 -0.16 -0.10 0.34 Myriad Genetics EPS misses by $0.09, misses on revenue
[5/5/2020 4:15 PM]		 14.82 -0.43 
(-2.82%)		 0.0 0.0 
(0.00%)		 9.24 - 48.40 1,598,918 1,109,140 0